Eye Journal
Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years – (Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years, Published online: 2019-01-04; | doi:10.1038/s41433-018-0309-7)
Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years, Published online: 04 January 2019; doi:10.1038/s41433-018-0309-7 Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years
Influence of peripheral corneal relaxing incisions during cataract surgery for corneal astigmatism up to 2.5 dioptres on corneal densitometry – (Influence of peripheral corneal relaxing incisions during cataract surgery for corneal astigmatism up to 2.5 dioptres on corneal densitometry, Published online: 2019-01-02; | doi:10.1038/s41433-018-0327-5)
Influence of peripheral corneal relaxing incisions during cataract surgery for corneal astigmatism up to 2.5 dioptres on corneal densitometry Influence of peripheral corneal relaxing incisions during cataract surgery for corneal astigmatism up to 2.5 dioptres on corneal densitometry, Published online: 02 January 2019; doi:10.1038/s41433-018-0327-5 Influence of peripheral corneal relaxing incisions during cataract surgery for corneal
A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom – (A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom, Published online: 2018-12-28; | doi:10.1038/s41433-018-0217-x)
A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom, Published online: 28 December 2018; doi:10.1038/s41433-018-0217-x A prospective study of the incidence, associations and outcomes of ocular surface squamous
Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis – (Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis, Published online: 2018-12-21; | doi:10.1038/s41433-018-0321-y)
Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis, Published online: 21 December 2018; doi:10.1038/s41433-018-0321-y Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in
Cambridge Ophthalmological Symposium 2018: introduction and reflections on the day – (Cambridge Ophthalmological Symposium 2018: introduction and reflections on the day, Published online: 2018-12-19; | doi:10.1038/s41433-018-0320-z)
Cambridge Ophthalmological Symposium 2018: introduction and reflections on the day Cambridge Ophthalmological Symposium 2018: introduction and reflections on the day, Published online: 19 December 2018; doi:10.1038/s41433-018-0320-z Cambridge Ophthalmological Symposium 2018: introduction and reflections on the day